Peter’s practice involves developing patent portfolios for early stage companies, conducting due diligence investigations, conducting analysis and rendering clearance and freedom-to-operate opinions, rendering patentability opinions and conducting general intellectual property litigation.
Peter advises clients regarding intellectual property protection and enforcement strategies to develop comprehensive and cost-effective market-competitive strategies for clients. His patent practice entails drafting and prosecuting domestic and international patent applications in the fields of biotechnology, nanotechnology, medical devices, and mechanical arts, including genomics, peptides, cardiovascular stents, vascular grafts, diagnostic systems and methods, drug delivery systems, optical imaging systems, ultrasound imaging systems, catheter based imaging systems, vacuum deposition processes, nanoparticles, nanocomposites, MEMS, polymers, oxygenator systems, RFID systems, e-commerce, composite materials, and blanket technologies.
Peter assists clients by negotiating and drafting license agreements, technology transfer agreements, confidentiality and consulting agreements and clinical trial agreements. Peter also provides pro bono legal services in mentoring start-up high technology companies in a Chicago-based incubator.
Peter received his bachelor’s degree from the University of California at Berkeley in Molecular & Cell Biology with an emphasis in Biochemistry. During college, Peter interned at Genentech, Affymax, and Sugen where he conducted research in vascular signal transduction, high-throughput drug screening, and novel substrate identification in cancer regulation. After college, Peter was a Research Associate at the UCSF Ernest Gallo Clinic & Research Center for several years, conducting neuroscience research in the fields of Addiction, Alcoholism, Alzheimer’s, and Anxiety. He investigated the inhibition of ENT-1 by alcohol and the role of PKC epsilon in Alzheimer’s Disease, contributing to the publication Protein Kinase C Epsilon Increases Endothelin Converting Enzyme Activity and Reduces Amyloid Plaque Pathology in Transgenic Mice , PNAS, 21, 8215-8220 (2006).
Peter received his J.D. from Chicago-Kent College of Law with an Intellectual Property Certificate. Peter placed on Dean’s List and received the CALI award for academic excellence in patent law. During law school, he served as an Associate Editor for the Journal of Intellectual Property and published an article titled, “Written Description Requirement in Nanotechnology: Clearing a Patent Thicket” ; 88 J. Pat. & Trademark Off. Soc’y 489 (2006). Peter’s previous work experience includes clerking at the Law Offices of Alter & Weiss, where he prepared and prosecuted patent applications, conducted an infringement analysis for a medical device, and initiated PCT applications for international prosecution. Additionally, Peter was a legal intern at the IP-Patent Clinic at Chicago-Kent College of Law, where he conducted patentability analysis and prior art searches for synthesis methods in nanotechnology and business methods.
Peter is admitted to practice in Illinois, before the United States District Court for the Northern District of Illinois, and before the United States Patent & Trademark Office.